Wall Street Zen Upgrades HealthEquity (NASDAQ:HQY) to Buy

HealthEquity (NASDAQ:HQY) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday.

HQY has been the subject of a number of other research reports. JMP Securities set a $122.00 price target on HealthEquity in a research report on Thursday, December 4th. Citigroup reissued an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Citizens Jmp raised their price target on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research note on Thursday, December 4th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a report on Thursday, December 4th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $119.60.

HealthEquity Stock Down 1.6%

Shares of NASDAQ HQY opened at $84.00 on Monday. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity has a 52 week low of $74.07 and a 52 week high of $116.65. The firm’s fifty day moving average is $95.56 and its 200 day moving average is $94.28. The company has a market cap of $7.18 billion, a price-to-earnings ratio of 38.53, a PEG ratio of 1.23 and a beta of 0.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter in the prior year, the company posted $0.78 EPS. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities research analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 13,959 shares of company stock valued at $1,344,957 in the last quarter. 1.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in HQY. Simplify Asset Management Inc. purchased a new position in shares of HealthEquity during the 3rd quarter valued at about $1,498,000. Westfield Capital Management Co. LP increased its holdings in HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after acquiring an additional 701,819 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. bought a new stake in HealthEquity during the 2nd quarter worth approximately $492,000. Artisan Partners Limited Partnership lifted its holdings in HealthEquity by 44.8% during the second quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company’s stock valued at $65,124,000 after purchasing an additional 192,252 shares in the last quarter. Finally, First American Bank purchased a new position in HealthEquity during the third quarter valued at approximately $1,633,000. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.